Candel Therapeutics, Inc. CADL Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s interest paid?
- Candel Therapeutics, Inc. (CADL) reported interest paid of $1.22M in Q1 2026.
- How has Candel Therapeutics, Inc.'s interest paid changed year-over-year?
- Candel Therapeutics, Inc.'s interest paid increased by 384.9% year-over-year, from $252K to $1.22M.
- What is the long-term trend for Candel Therapeutics, Inc.'s interest paid?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s interest paid has grown at a 3.6% compound annual growth rate (CAGR), from $1.15M to $1.28M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.